☆ 4.6 Letter

Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Get Full Text
Add to Collection

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 95, Issue 9, Pages E232-E235

Publisher

WILEY
DOI: 10.1002/ajh.25858

Keywords

-

Categories

Hematology

Funding

  1. MD Anderson Cancer Center Support Grant [P30 CA016672]
  2. Leukemia and Lymphoma Society Specialized Center of Research (LLS SCOR)
  3. Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  4. Multiple Myeloma Research Foundation
  5. Chapman Perelman Foundation
  6. University of Texas MD Anderson Moon Shot Program
  7. National Cancer Institute [R01 CA184464, R01 194264, U10 CA032102]
  8. Leukemia & Lymphoma Society [SCOR-12206-17]
  9. Adelson Medical Research Foundation
  10. Brock Family Myeloma Research Fund
  11. Jean Clarke High-Risk Myeloma Research Fund

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.